PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Adding Value to Nature-Identical Therapies Portfolio
Stock split, CSE listing show evidence of company’s shareholder commitment PreveCeutical balancing need for unique profit-building intellectual property with mission to offer affordable products to patients Manufacturer agreement, licensed shipments advance CBD therapy research Alternative medicines market valued at more than $40 billion PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) dedication to developing preventative medical therapies based on the identified health benefits of natural substances in controllable formulations that are both affordable to consumers and potentially profitable to investors is on display in the company’s recent shareholder-approved forward stock split and the opening of trade on the Canadian…